Cardiomyopathy in Duchenne Muscular Dystrophy: Current Value of Clinical, Electrophysiological and Imaging Findings in Children and Teenagers
Related Experiment Video
Updated: Jul 25, 2026

Noninvasive Assessment of Cardiac Abnormalities in Experimental Autoimmune Myocarditis by Magnetic Resonance Microscopy Imaging in the Mouse
Published on: June 20, 2014
S Dittrich1, M Tuerk2, G Haaker3
1Pediatric Cardiology, University Hospital, Erlangen, Germany.
Insights
Cardiac MRI is the most sensitive tool for detecting early heart dysfunction in Duchenne muscular dystrophy (DMD) patients, enabling timely interventions. This study compared various cardiac diagnostic methods in DMD.
Area of Science:
- Cardiology
- Neuromuscular Disorders
- Medical Imaging
Background:
- Progressive cardiomyopathy (CMP) is a leading cause of mortality in Duchenne muscular dystrophy (DMD).
- Early diagnosis of cardiac dysfunction is crucial for managing DMD patients.
Purpose of the Study:
- To assess and compare the efficacy of various cardiac diagnostic procedures for the preterm diagnosis of cardiac dysfunction in DMD.
- To determine the most sensitive imaging modality for identifying myocardial changes in DMD.
Main Methods:
- Cross-sectional study involving 39 male DMD patients (aged 6-20 years).
- Cardiac assessment included ECG, Holter ECG, heart rate variability (HRV), B-type natriuretic peptide (BNP), echocardiography (TTE), tissue Doppler Imaging (TD), and cardiac MRI with Late Gadolinium enhancement (LE) and wall motion analysis (WMA).
Main Results:
- 56% of patients had repolarization abnormalities and 76% showed altered HRV.
- Subnormal ventricular function was detected in 25% by TTE and 34% by MRI.
- MRI revealed LE and WM abnormalities in 89% of patients, with reduced LE extent after steroid treatment.
Conclusions:
- Cardiac MRI with LE and WM analysis is superior to TTE and TD for evaluating myocardial damage in DMD.
- ECG and HRV abnormalities are common but not strongly predictive of ventricular dysfunction.
- Early cardiac MRI is essential for identifying myocardial changes and guiding therapeutic strategies in DMD.
Background:
Progressive cardiomyopathy (CMP) is one main cause of death in DMD. This cross-sectional assessment of different cardiac diagnostic procedures focusses on preterm diagnosis of cardiac dysfunction.
Patients:
39 male DMD patients aged 6-20 years were included. 6 patients were still ambulatory, 21 patients received corticosteroid therapy.
Methods:
All patients were investigated by ECG, Holter ECG and heart rate variability (HRV), B-type natriuretic peptide (BNP), echocardiography (TTE), tissue Doppler Imaging (TD) and magnetic resonance imaging (MRI) with Late Gadolinium enhancement (LE) and segmental wall motion analysis (WMA).
Results:
56% of the patients showed repolarization abnormalities and 76% altered HRV. Subnormal ventricular function was found in 25% by TTE and in 34% by MRI. TD differed from normal controls only in the apical septum. In MRI 89% of the patients showed different distribution and intensity of LE and WM restriction. The extent of LE was less in patients after steroid treatment (p<0.05).
Discussion:
MRI with segmental LE- and WM-analysis seems to be superior to TTE and TD in exploring regional distribution and severity of damage of the myocardium. ECG and HRV abnormalities are common in DMD-patients but not tightly predictive for segmental and global left ventricular dysfunction. Targeted treatment of CMP in DMD needs prospective evaluation.
Conclusion:
A timely cardiac MRI is the most sensitive investigation for the identification of early myocardial changes in DMD which is a prerequisite for early interventions and therapeutic strategies.
Related Concept Videos
Satellite Stem Cells and Muscular Dystrophy
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy V: Interprofessional Care

